Integra Lifesciences Holdings (IART) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Integra Lifesciences Holdings (IART) over the last 15 years, with Q4 2024 value amounting to $396.9 million.
- Integra Lifesciences Holdings' Accumulated Depreciation & Amortization rose 802.18% to $396.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $396.9 million, marking a year-over-year increase of 802.18%. This contributed to the annual value of $396.9 million for FY2024, which is 802.18% up from last year.
- Latest data reveals that Integra Lifesciences Holdings reported Accumulated Depreciation & Amortization of $396.9 million as of Q4 2024, which was up 802.18% from $367.4 million recorded in Q4 2023.
- In the past 5 years, Integra Lifesciences Holdings' Accumulated Depreciation & Amortization ranged from a high of $396.9 million in Q4 2024 and a low of $282.8 million during Q4 2020
- In the last 5 years, Integra Lifesciences Holdings' Accumulated Depreciation & Amortization had a median value of $329.7 million in 2022 and averaged $338.4 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 15839.93% in 2020, then soared by 471.78% in 2022.
- Integra Lifesciences Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $282.8 million in 2020, then grew by 11.32% to $314.9 million in 2021, then grew by 4.72% to $329.7 million in 2022, then increased by 11.44% to $367.4 million in 2023, then grew by 8.02% to $396.9 million in 2024.
- Its Accumulated Depreciation & Amortization was $396.9 million in Q4 2024, compared to $367.4 million in Q4 2023 and $329.7 million in Q4 2022.